Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Scientists gain new insights into function of NLRC3

Dec. 28, 2018

Platform could prove broad strategy against emerging viruses

Dec. 24, 2018

Aimmune Therapeutics submits IND application for AR-201 as treatment of egg allergy

Dec. 24, 2018

Pfizer to discontinue STRIVE study of S. aureus vaccine due to futility

Dec. 21, 2018

Kalytera reports first cohort interim data from phase II trial of CBD in acute GvHD

Dec. 21, 2018

LncRNAs are gene trainers

Dec. 21, 2018

NovImmune presents data supporting approval of emapalumab for hemophagocytic lymphohistiocytosis

Dec. 21, 2018

FDA approves Envarsus XR to prevent organ rejection in de novo kidney transplant patients

Dec. 20, 2018

European Commission approves Dengvaxia for prevention of dengue

Dec. 19, 2018

Lilly signs collaboration and license agreement for Aduro's cGAS-STING pathway inhibitor program

Dec. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...